混合扩散和瘤形式的宾尼尔综合征成功地用易布鲁替尼治疗
Junid A Naveed Ahmad1, Brett A Schroeder1,2, John Paul T Yun3
1Virginia Mason Medical Center, Cancer Institute, Seattle, WA, USA.
Case reports in oncology
|November 10, 2023
概括
宾尼尔综合征 (BNS) 是一种罕见的中枢神经系统并发症,是沃尔登斯特罗姆巨型球蛋白血症 (WM) 的一种罕见的并发症,可以用布鲁顿氨酸激酶抑制剂 (BTKIs) 有效治疗. 本案例研究突出了一个患者,他通过IBRUTINIB (BTKI) 实现了显著的临床和放射性改善,证明了IBRUTINIB对BNS的治疗潜力.
科学领域:
- 神经学 神经学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 宾尼尔综合征 (Bing-Neel syndrome,简称BNS) 是一种罕见的中枢神经系统 (中枢神经系统) 症状,表现为沃尔登斯特罗姆巨型球蛋白血症 (WM).
- BNS涉及恶性淋巴细胞细胞透到中枢神经系统,导致各种神经症状.
- 最近,BNS的标准化诊断标准和治疗选择得到了改进.
研究的目的:
- 介绍一个成功用布鲁顿氨酸激酶抑制剂 (BTKI) 治疗的Bing-Neel综合征病例.
- 讨论MYD88 L265P突变测试在BNS诊断中的作用.
- 突出BTKI在管理BNS中的不断扩大的治疗潜力.
主要方法:
- 一个70岁的男性病例介绍,他有WM病史,有神经症状.
- 诊断工作包括脑部MRI,血清和脑脊液研究,以及立体脑部活检.
- 治疗包括每天口服布鲁丁尼布 (BTKI).
主要成果:
- 大脑活检证实淋巴细胞淋巴瘤与MYD88 L265P突变.
- 患者对ibrutinib有显著的临床和放射性反应.
- 这些积极的反应已经持续了超过31个月.
结论:
- 布鲁顿氨酸激酶抑制剂 (BTKI) 具有很高的中枢神经系统透性,并为BNS提供了一种新的治疗策略.
- 用BTKI有效治疗BNS可以改善患者的生存率和生活质量.
- 在BNS管理的背景下,MYD88 L265P突变测试至关重要.
关键词:
宾尼尔综合征 (Bing-Neel综合征) 是一种布鲁顿氨酸激酶抑制剂 布鲁顿氨酸激酶抑制剂淋巴质细胞性淋巴瘤是淋巴细胞性淋巴瘤.MYD88 L265P 在线阅读沃尔登斯特罗姆的巨型球蛋白血症更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
